TCL Archive Pooled Analysis of Two LUX-Lung Trials Shows Prolonged Survival with Afatinib June 27, 2014
TCL Archive IARC Says Evidence Supports Mammography Screening For 50-69, Limited Evidence For 40-49 March 22, 2002
TCL Archive US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma. July 28, 2000
